RIT Capital Partners Overview
RIT Capital Partners is one of the UK's largest listed investment trusts and the principal public investment vehicle historically associated with the English branch of the Rothschild family, which remains its largest shareholder with a holding the company describes as approximately 22%. It runs a single, unconstrained, multi-asset global portfolio organised into three pillars — Quoted Equities (long-term range 30–60% of NAV), Private Investments (20–40%) and Uncorrelated Strategies (20–40%) — overlaid with active currency and macro exposure management. Its corporate objective combines long-term capital growth with capital preservation, measured against CPI plus 3% and a 50% sterling-hedged MSCI ACWI. Since its 1988 listing it has compounded NAV per share total return at roughly 10.6–10.7% per annum. Its differentiation rests on network-driven access to hard-to-reach private companies (SpaceX, Anthropic, Databricks, Stripe, Cognition) and closed specialist managers, permanent capital, and an internal manager. Its central challenge is a persistent 20–30% share-price discount to NAV.
What the company does
RIT is a closed-ended, listed investment company approved by HMRC as an investment trust and classified as a UK Alternative Investment Fund. Its investment management, administration and company secretarial functions are delegated to JRCM, which is a subsidiary of RIT rather than a third-party manager. This makes RIT "self-managed": shareholders bear the manager's operating costs directly through the NAV rather than paying a percentage management fee to an external firm. A second subsidiary, Spencer House Limited (SHL), manages the Group's historic properties in St James's, London, including Spencer House itself, and operates an events business that the company describes as profitable (2025 Annual Report).
Company's own description (paraphrased from the 2025 Annual Report)
The company describes its purpose as growing shareholders' wealth meaningfully over time through a diversified and resilient global portfolio. It cites three differentiators: a flexible mandate across structures, asset classes and geographies; access to exclusive opportunities not typically available to individual investors; and internal expertise combined with a global network of specialist partners. Its formal Corporate Objective is to deliver long-term capital growth while preserving shareholders' capital, investing without a formal benchmark but aiming to exceed relevant indices over time. Its Investment Policy is to invest in a widely diversified international portfolio of quoted and unquoted assets and to allocate part of the portfolio to exceptional external managers.
Business and "revenue" model
| Element | Description |
|---|---|
| Economic engine | Change in fair value of a ~£4.3–4.7bn portfolio (capital gains/losses) plus modest investment income (dividends, interest, fund distributions classed as income) |
| Revenue mix analogue | Investment income £13.2m vs fair-value gains £346.8m in H1 2026, i.e., over 95% of total income is capital in nature (H1 2026 report) |
| Product/service/subscription/licensing mix | Not applicable — RIT sells no products or services to third parties other than SHL's events/premises activity (£2.4m segment income in H1 2026) |
| Cost model | Internal manager costs (staff, AIS bonuses, LTIP), third-party fund fees embedded in underlying fund NAVs, finance costs on ~£300–360m borrowings |
| Ongoing charges figure (RIT's own) | 0.73% (FY2025) vs 0.76% (FY2024), excluding performance-related pay and underlying fund costs (2025 AR) |
| Distribution policy | Progressive dividend paid from capital reserves (45p planned for 2026); share buybacks; one-off £300m tender offer (July 2026) |
| Funding | Permanent equity capital; RCFs (ICBC, SMBC, BNP Paribas), BNP 3-year term loan, 2015 senior loan notes |
Value-chain position and end-markets
RIT sits at the capital-allocator layer of the investment value chain. It is simultaneously:
-
a direct investor in listed equities (e.g., Galderma, Booking Holdings, S&P Global) and in private companies, often via co-investment vehicles managed by a general partner;
-
a limited partner in third-party private funds (Thrive, Greenoaks, Ribbit, Iconiq, BDT, Hillhouse and others);
-
an allocator to specialist public-equity managers (Discerene, BlackRock Strategic Equity, 3D Opportunity, Perseverance, Parvus, Morant Wright, healthcare specialists) and absolute-return/credit managers (Tresidor, Attestor, STA, LibreMax, Woodline, ILEX, Deem Global);
-
a macro/currency overlay manager using futures, forwards and options.
Customer types: RIT's "customers" are its shareholders: UK retail investors via platforms (Hargreaves Lansdown, Interactive Investor, Fidelity), wealth managers (Evelyn Partners, Rathbones, Charles Stanley), institutions (Aberdeen) and the Rothschild family/foundation.
End-markets "served" (i.e., markets it invests in): global listed equities; US venture and growth private equity (AI, enterprise software, fintech, space); credit and hedge-fund strategies; government bonds; gold and commodities; London prime real estate (St James's).
Independent characterisation
RIT is best characterised as a listed multi-family-office-style endowment portfolio with a structural tilt toward US technology private markets accessed via relationships. Its return profile has historically been "equity-like with lower volatility" (10-year monthly NAV volatility 7.3% p.a. vs 12.0% for ACWI (50% £), per the 2025 AR), but its capture of strong, narrow, US mega-cap-led equity rallies has been poor (e.g., ACWI (50% £) +17.1% vs RIT NAV +13.5% in 2025; +12.5% vs +9.0% in H1 2026). The business model's binding constraint is not investment returns per se but the conversion of NAV returns into shareholder returns, which is impaired by a wide and persistent discount driven by investor scepticism over private-asset valuations, cost complexity and the post-founder era.
Strategy
Stated strategy themes (2025 AR and H1 2026 report)
Purpose: grow wealth meaningfully over time through a diversified and resilient global portfolio.
Three pillars: with long-term ranges (QE 30–60%, PI 20–40%, US 20–40%), overlaid with currency and macro exposure management.
Differentiators: access (network and heritage), flexibility (permanent capital, unconstrained mandate), expertise (internal team plus specialist partners).
Two structural investment themes: (CEO letters 2025 and H1 2026): (1) a fragmented, multipolar world — favouring defence, energy independence, industrial resilience, non-US markets, commodities and gold; (2) the AI-driven technology revolution — with management arguing value will migrate from infrastructure to applications, expressed mainly via private markets (Anthropic, Databricks, Cognition, Stripe).
Values: entrepreneurial, performance-focused, collaborative, integrity (values framework refreshed with external consultants in 2025).
Strategic initiatives announced in the last 24 months
| Date | Initiative | Detail / target | Status |
|---|---|---|---|
| Feb–Mar 2024 (carried through 2025) | Reduce Private Investments to a quarter–third of NAV | 31.7% at Dec 2025 (achieved) | Achieved; rose to 33.4% Jun 2026 and ~36% Sept 2026 on SpaceX-driven uplift and new deployment |
| 2024–2026 | Concentration of direct quoted equities and fund manager line-ups | Fewer, higher-conviction managers; legacy exits | Ongoing |
| 2,025 | Enhanced private-investment disclosure; dedicated presentations; retail webinar programme; podcasts and LinkedIn | Investor-relations upgrade | Ongoing; AIC Best Shareholder Engagement award (Oct 2026) |
| 2,025 | Treasury/financing: £100m SMBC RCF; repayment of first 2015 loan-note series | Liquidity flexibility | Completed |
| 8 Jul 2026 | Package of strategic initiatives: (i) £300m tender at 15% discount to 30 June NAV; (ii) review of dividend policy including higher dividend from 2027; (iii) continued active buybacks; (iv) disciplined capital-allocation framework | Address persistent discount, improve liquidity | Tender completed 24–29 Jul 2026; dividend review outcome due with FY2026 results (March 2027) |
| Post-Jun 2026 | Additional £50m ICBC facility on existing terms | Liquidity | Completed |
| 2,026 | Updated Responsible Investment Framework and Policy | ESG integration | Published |
Medium-term targets/guidance
RIT does not publish financial guidance. Its benchmarks are:
Absolute KPI: NAV total return above CPI + 3% per annum.
Relative KPI: NAV total return above ACWI (50% £).
Shareholder KPI: total shareholder return.
Dividend: progressive, maintain-or-increase approach subject to capital preservation; 45p for 2026; possible step-up from 2027.
Buybacks: continue where accretive while retaining investment flexibility; authority to repurchase up to 14.99% renewed April 2026.
Products & Services
For an investment trust, the "product" is the single listed share offering exposure to a curated portfolio. The catalogue below lists the investment "product lines" (pillars, sub-strategies and named flagship holdings) as disclosed in the 2025 Annual Report (positions at 31 December 2025) and updated with 2026 disclosures.
The listed share (the only externally sold product)
| Attribute | Detail |
|---|---|
| Product | RIT Capital Partners plc ordinary £1 shares |
| Target customer | UK retail investors (via platforms), wealth managers, family offices, institutions seeking a "core diversifier" |
| Pricing | Market price (2,505p on 16 Oct 2026) vs NAV 3,209p (30 Sept 2026) |
| Costs | OCF 0.73% (FY2025), excluding underlying fund fees and performance-related pay |
| Income | 45p planned 2026 dividend (two instalments of 22.5p: 24 Apr 2026 paid; 30 Oct 2026 payable); YTD annualised yield 1.8% (Sept 2026 factsheet) |
| Wind-up | Unlimited life (AIC) |
Pillar 1 — Quoted Equities (43.3% of NAV at Dec 2025; 45% at Sept 2026)
| Holding | Country | Sector | Value GBP Mn | % NAV |
|---|---|---|---|---|
| Galderma Group AG | Switzerland | Healthcare (dermatology); bought at March 2024 IPO; share price more than tripled since flotation per company | 43.4 | 1.1 |
| Booking Holdings | US | Consumer discretionary | 38.2 | 0.9 |
| S&P Global | US | Financials | 32.8 | 0.8 |
| Legrand SA | France | Industrials | 31.1 | 0.8 |
| The Travelers Companies | US | Financials | 29.3 | 0.7 |
| Amazon.com | US | Consumer discretionary | 28.6 | 0.7 |
| Mastercard | US | Financials | 28.1 | 0.7 |
| Reckitt Benckiser Group | UK | Consumer staples | 28.1 | 0.7 |
| Intercontinental Exchange | US | Financials | 27.1 | 0.7 |
| Texas Instruments | US | Information technology | 25.5 | 0.6 |
| Procter & Gamble | US | Consumer staples | 22.8 | 0.6 |
| McDonald's | US | Consumer discretionary | 19.4 | 0.5 |
| Other stocks | Various | Various | 58.3 | 1.5 |
| Quoted stocks within private funds (reallocation) | Various | Various | 175.2 | 4.3 |
| Manager / Fund | Region | Style | Value GBP Mn | % NAV |
|---|---|---|---|---|
| Discerene | Global | All-cap, value bias | 192.4 | 4.8 |
| BlackRock Strategic Equity | Global | All-cap, diversified | 164.1 | 4.1 |
| 3D Opportunity | Japan | All-cap, diversified (corporate reform/activism) | 162.8 | 4.0 |
| Perseverance Asset Management Int'l | China | All-cap, long-biased | 128.7 | 3.2 |
| Parvus European Opportunities | Europe | All-cap, value bias (new in 2025) | 119.0 | 2.9 |
| HCIF Offshore | US | Healthcare | 116.2 | 2.9 |
| Morant Wright | Japan | SMID-cap, value | 86.1 | 2.1 |
| DG Offshore | Global | Healthcare | 79.4 | 2.0 |
| Other funds | Various | Various | 30.4 | 0.7 |
Direct stocks — named holdings at 31 Dec 2025 (2025 AR Investment Portfolio):
Thematic baskets (Dec 2025): Gold miners (£76.3m, 2.0% NAV); Emerging markets (3.1% exposure); European sovereignty (1.9% exposure); Other metals – mining and suppliers (0.9% exposure).
Notable 2025 disposals: Coupang (exited over regulatory risk after a customer-data breach), Somnigroup, National Grid, Constellation Energy (gains); QuidelOrtho and VF Corp (catalysts failed to materialise). 2026 addition: SpaceX (transferred in at IPO, June 2026). Seibu (Japanese rail/hospitality) referenced as a contributor in 2025.
Equity funds — named managers at 31 Dec 2025:
2026 addition: Carrhae Capital (emerging-markets specialist) appointed in H1 2026 (H1 2026 CEO letter).
Quoted Equities exposure by theme (net, Dec 2025): Direct — Quality 24%, Emerging markets 7%, Commodities 7%, European sovereignty 5%; Funds — Emerging markets 17%, Japan 17%, Biotech 12%, Quality 11% (2025 AR chart).
Pillar 2 — Private Investments (31.7% of NAV at Dec 2025; 36% at Sept 2026)
| Company | Sector | Value GBP Mn | % NAV | Notes |
|---|---|---|---|---|
| SpaceX | AI and advanced technologies / space | 102.3 | 2.5 | First invested Nov 2024; IPO June 2026 (now Quoted Equities) |
| Motive | Enterprise software | 69.5 | 1.7 | Written down in 2025 on reassessed near-term outlook |
| Epic Systems | Healthcare software | 37.6 | 0.9 | — |
| Kraken | Fintech / crypto exchange | 33.7 | 0.8 | — |
| Blueground | Consumer (furnished rentals) | 21.9 | 0.5 | — |
| Databricks | Enterprise software / data and AI | 16.9 | 0.4 | New in 2025; added in H1 2026 |
| Dandy | Enterprise software (dental tech) | 13.1 | 0.3 | — |
| Puck | Consumer / media | 8.2 | 0.2 | — |
| Brex | Fintech | 7.9 | 0.2 | — |
| Anchorage Digital | Fintech / digital-asset custody | 7.4 | 0.2 | — |
| Anthropic | AI and advanced technologies | 7.4 | 0.2 | New in 2025; added in H1 2026 |
| Airtable | Enterprise software | 6.8 | 0.2 | — |
| Other direct | Various | 59.5 | 1.6 | — |
| Fund family | Region | Strategy | Value GBP Mn | % NAV |
|---|---|---|---|---|
| Thrive | US | Growth equity | 145.9 | 3.6 |
| Greenoaks Capital | US | Growth equity | 135.3 | 3.3 |
| Ribbit Capital | US | Early stage and growth (fintech) | 116.4 | 2.9 |
| Iconiq | US | Growth equity | 111.6 | 2.8 |
| BDT Capital | US | Private equity | 68.1 | 1.7 |
| Hillhouse | China | Private equity | 53.8 | 1.3 |
| Hunter Point | US | Private equity (GP stakes) | 52.7 | 1.3 |
| LCV | US | Early stage | 40.6 | 1.0 |
| Arch Venture | US | Life sciences | 24.2 | 0.6 |
| Firstminute Capital | Europe | Early stage | 23.8 | 0.6 |
| LionTree Investment Fund | US | Private and growth equity | 22.8 | 0.6 |
| Mithril | US | Growth equity | 16.4 | 0.4 |
| Westcap | US | Growth equity | 16.0 | 0.4 |
| Twenty VC | US | Early stage | 15.8 | 0.4 |
| Innovius Capital | US | Growth equity | 14.5 | 0.4 |
| Founders Fund | US | Early stage | 13.5 | 0.3 |
| Sound Ventures | US | Early stage | 13.2 | 0.3 |
| Eight Partners | US | Early stage | 11.0 | 0.3 |
| HSG (formerly Sequoia China) | China | Growth equity | 8.7 | 0.2 |
| Sky9 | China | Early stage | 8.7 | 0.2 |
| Corsair | US | Private equity | 8.2 | 0.2 |
| Future Capital Discovery | Asia | Early stage | 7.2 | 0.2 |
| K2 | Asia | Early stage | 6.9 | 0.2 |
| Blackstone Tactical Opportunities | US | Private equity | 6.7 | 0.2 |
| Other private funds | Various | Various | 120.0 | 2.9 |
Direct private investments at 31 Dec 2025 (£392.2m, 9.7% NAV):
New directs in H1 2026: Cognition (agentic AI; a top-five direct position by Sept 2026, which raised a round in September 2026 above RIT's carrying value) and Stripe (payments) (H1 2026 report; Sept 2026 factsheet).
Realised directs 2025: Webull (largest 2025 exit), Scale AI, Xapo Bank — exits at an aggregate 112% uplift to prior carrying values, 2.2x cost, 23% IRR (2025 AR).
Private portfolio by sector (look-through, % of pillar, 2025 AR): Enterprise software 25%; Fintech and financial services 25%; AI and advanced technologies 15%; Healthcare and life sciences 15%; Consumer 15%; Industrials and other 5%. Vintage mix: 2021–2025 40%; 2017–2020 38%; 2013–2016 14%; prior 8%.
Pillar 3 — Uncorrelated Strategies (25.6% of NAV at Dec 2025; 17% at Sept 2026)
| Holding (Dec 2025) | Type | Value GBP Mn | % NAV |
|---|---|---|---|
| Tresidor funds | Credit (Europe) | 171.2 | 4.3 |
| Attestor Value fund | Credit (Global) | 113.8 | 2.8 |
| Atos corporate bond | Credit (Europe) | 41.4 | 1.0 |
| Chicago Atlantic Credit Opportunities | Credit (US) | 17.2 | 0.4 |
| Other credit | Credit | 17.7 | 0.4 |
| STA fund | Systematic multi-strategy | 77.1 | 1.9 |
| LibreMax fund | Absolute return | 76.4 | 1.9 |
| Woodline fund | Equity market neutral | 71.4 | 1.8 |
| ILEX fund | Equity market neutral (Europe) | 71.1 | 1.8 |
| JJJ Feeder fund | Macro | 59.9 | 1.5 |
| Deem Global Macro fund | Discretionary macro (early investor, Sept 2024) | 30.3 | 0.7 |
| Other absolute return | Various | 26.3 | 0.6 |
| St James's properties | Investment property (UK) | 27.0 | 0.7 |
| Spencer House (incl. contents and fine art) | Investment property (UK) | 25.8 | 0.6 |
| Gold (futures; 4.0% exposure) | Commodity | 7.0 | 0.2 |
| Other real assets | Various | 5.7 | 0.1 |
| US Treasury Note | Government bonds | 105.6 | 2.6 |
| UK Treasury Gilt | Government bonds | 93.0 | 2.3 |
2025–2026 activity: Exits of ARCM (fund wind-down) and LionTree loan note (repaid above carrying value); exit of California carbon credits; gold returned 46% in 2025; oil position established in February 2026 ahead of the Middle East conflict and exited at a gain; gold trimmed in H1 2026; government bonds and rates reduced to ~0% NAV by Sept 2026.
Currency overlay
Currency forwards (£21.0m fair value, 0.5% NAV at Dec 2025) and options are used to manage the sterling/US dollar exposure. Hedging limited the FY2025 currency drag to -2.9% vs an unhedged -5.1% (2025 AR).
Financial Narrative
Core per-share and NAV metrics (Annual reports/results RNSs FY2021–FY2025)
FY2021 discount derived from 2,750p/2,794p. Benchmark rows from September 2026 factsheet annual return table.
Half-year and latest:
Sept 2026 net assets shown as approximately £4.0bn (rounded in factsheet) after the £300m tender.
Income statement
FY2023–FY2024 from FY2024 results coverage (Alliance News/MarketScreener summarising the RNS); FY2025 operating expenses from the OCF reconciliation in the H1 2026 glossary.
Margin analogues: Gross margin, EBITDA and EBITDA margin are not applicable to an investment trust. The revenue account (income less revenue-allocated expenses) was negative in both H1 2025 (-£2.7m) and H1 2026 (-£4.4m), meaning dividends are funded from capital reserves, as the company discloses. Operating expenses as a share of average net assets: 1.07% gross / 0.73% OCF (FY2025).
Revenue CAGR: Not meaningful. The closest analogue — NAV per share total return compounded FY2021–FY2025 — is 37.4% over five years (6.6% annualised), matching the company's reported 5-year figure at Dec 2025. NAV per share (ex-dividends) grew from 2,794p to 2,921p, a 1.1% annual rate, illustrating that much of the value was distributed via dividends (~£60m p.a.) and buybacks.
Balance sheet
Net debt derived. Goodwill/intangibles: none reported on the consolidated balance sheet.
Fair-value hierarchy (GBP M):
In H1 2026, £579.9m was transferred from Level 3 to Level 2 on receipt of new information about underlying investments (largely fund reclassification; also SpaceX IPO). Level 3 represents roughly 45% of investments at June 2026 vs 51% at Dec 2025.
Prior-year balance sheet points: Net assets £3,573m (Dec 2023), £3,731.2m (Dec 2024). Gearing 8.9% (Dec 2024).
Cash flow
Annual capital returns (company disclosures):
Buyback figures from FY2023 results coverage (2022, 2023), FY2024 results (2024), 2025 AR (2025) and Sept 2026 factsheet (2026 YTD, of which £300m tender). 2026 dividends: £30.7m paid in April plus ~£28m due 30 October on ~124.4m shares (derived estimate; flagged). Cumulative since 2023: £505m returned via buybacks and dividends to Dec 2025 (2025 AR); >13% of share capital (£392m) repurchased via regular buybacks to June 2026, before the tender.
Ratios
Derived ratios: FY2024 ROE = £305.0m / average of £3,573m and £3,731m. H1 2026 ROE and ROA are non-annualised (£333.5m / average equity £4,164.6m; £333.5m / £4,749.9m). H1 2025 interest coverage was 6.4x (£123.2m / £19.2m). ROIC, current ratio, net debt/EBITDA, asset turnover and cash conversion cycle are not meaningful for an investment trust and are marked not applicable.
Commentary on trends, inflections and drivers
FY2021 — peak. A 23.6% NAV return and 35.1% TSR, with shares near NAV, marked the high point of the post-pandemic tech/private-markets cycle. Private investments had contributed roughly 34% of NAV over 2020–21 (Feb 2023 NAV RNS), which set up the subsequent reversal.
FY2022 — reversal. NAV fell 13.3%, broadly in line with ACWI (-12.9%), but private investments detracted 6.2% of NAV. TSR of -21.5% reflected the discount opening from near zero to 11%. This is the origin of the current discount problem: investors began to doubt private-asset marks.
FY2023 — the "lost year" for shareholders. NAV TR of only 3.2% against ACWI (50% £) of 18.4%, and a TSR of -9.6% as the discount doubled to ~22%. Management turnover (CIO and CEO) and the private-asset overhang dominated. The response was aggressive buybacks (£163m) and a commitment to cut private exposure.
FY2024 — stabilisation. NAV TR 9.4%, pretax profit £305m, EPS 210.2p diluted. Private allocation was cut to ~33%; buybacks £80m; dividend raised 10.3% for 2025. Still lagged ACWI (50% £) at 20.1%.
FY2025 — recovery. NAV TR 13.5% with all three pillars in double digits; TSR 16.9%. Direct privates returned 47.4% (Webull, Scale AI, Xapo exits; SpaceX uplift). Currency was the largest drag (-2.9%). Discount narrowed from -29.7% (Aug 2025) to -22.3%.
H1 2026 — record NAV but discount widens, then capital-allocation inflection. NAV TR 9.0% to a record 3,159p, but the discount widened to 27.5% as the share price lagged. The Board's July 2026 £300m tender was the inflection: accretive (+1.3%) and helped compress the discount to -17.4% at end-July and -20.8% at end-September. Finance costs fell 41% year-on-year (£11.4m vs £19.2m) on lower average drawn debt and rates.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Business | Contents |
|---|---|---|
RIT | Investment trust | The investment portfolio, borrowings, dividends and buybacks |
JRCM | Investment management / administration | Manager staff (48 at Jun 2026), management of RIT's net assets (AUM = RIT net assets of £4,289.1m at Jun 2026) |
SHL | Events / premises management | Spencer House and St James's properties management; events business (15 staff at Jun 2026) |
Segment income (GBP Mn)
| Segment income (GBP Mn) | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
RIT (investment trust) income and gains | 561 | 931 | -512 | 143 | 374 |
JRCM income | 53.4 | 74.3 | 50.3 | 39.0 | 49.5 |
SHL income | 1.9 | 2.8 | 3.7 | 4.1 | 4.4 |
Consolidation adjustments | -53.5 | -72.0 | -51.0 | -42.9 | -50.7 |
Results by Segment
| Segment metric (GBP Mn) | H1 2025 | H1 2026 |
|---|---|---|
RIT income/gains | 142.1 | 361.3 |
RIT operating expenses | -26.4 | -26.7 |
RIT profit before finance costs | 115.7 | 334.6 |
JRCM income | 23.0 | 25.2 |
JRCM operating expenses | -15.5 | -15.2 |
JRCM profit before finance costs | 7.5 | 10.0 |
SHL income | 2.0 | 2.4 |
SHL operating expenses | -2.0 | -2.1 |
SHL profit before finance costs | 0.0 | 0.3 |
Group total income/gains | 141.8 | 363.6 |
Group profit before finance costs | 123.2 | 344.9 |
Segment net assets (GBP Mn)
| Segment net assets (GBP Mn) | 30 Jun 2025 | 30 Jun 2026 |
|---|---|---|
RIT | 3,623.5 | 4,137.9 |
JRCM | 132.9 | 157.5 |
SHL | 1.6 | 1.8 |
Adjustments | -7.8 | -8.1 |
Total | 3,750.2 | 4,289.1 |
Revenue by Segment (%)
| Pillar allocation (% of NAV) | FY2022 | FY2023 | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|---|---|
Quoted Equities | — | 38.4 | 46.2 | 43.3 | 47.8 |
Private Investments | 40.7 | 35.9 | 33.4 | 31.7 | 33.4 |
Uncorrelated Strategies | — | 25.6 | 23.8 | 25.6 | 20.2 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansPillar return (%, local currency)
| Pillar return (%, local currency) | FY2025 | H1 2025 | H1 2026 |
|---|---|---|---|
Quoted Equities | 15.0 | 4.9 | 7.8 |
Private Investments | 18.3 | 9.0 | 9.1 |
Uncorrelated Strategies | 12.1 | 3.0 | 5.6 |
Pillar contribution to NAV total return (%)
| Pillar contribution to NAV total return (%) | FY2025 | H1 2025 | H1 2026 |
|---|---|---|---|
Quoted Equities | 6.9 | 2.4 | 3.3 |
Private Investments | 6.5 | 3.3 | 3.3 |
Uncorrelated Strategies | 3.4 | 0.9 | 1.5 |
Currency | -2.9 | — | 0.8 |
Liquidity, borrowings and other (incl. buyback accretion) | -0.4 | — | 0.1 |
Total NAV total return | 13.5 | 3.4 | 9.0 |
Segment Revenue
| Sub-pillar (FY2025) | % NAV FY2024 | % NAV FY2025 | Return % | Contribution % |
|---|---|---|---|---|
Quoted Equities – Direct | 23.8 | 16.6 | 8.6 | 2.1 |
Quoted Equities – Funds | 22.0 | 26.7 | 23.2 | 4.8 |
Private Investments – Direct | 10.1 | 9.7 | 47.4 | 3.7 |
Private Investments – Funds | 23.3 | 22.0 | 10.2 | 2.8 |
Absolute return and credit | 19.4 | 19.1 | 11.5 | 2.2 |
Government bonds and rates | 2.4 | 4.9 | -7.8 | -0.2 |
Real assets | 2.0 | 1.6 | 24.7 | 1.4 |
Dividends & Capital Returns and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
NAV per share, diluted (GBp) | 2,794 | 2,388 | 2,426 | 2,614 | 2,921 |
Share price at year end (GBp) | 2,750 | 2,125 | 1,882 | 1,986 | 2,270 |
Premium/discount to NAV (%) | -1.6 | -11.0 | -22.4 | -24.0 | -22.3 |
NAV per share total return (%) | 23.6 | -13.3 | 3.2 | 9.4 | 13.5 |
Share price total return (%) | 35.1 | -21.5 | -9.6 | 7.9 | 16.9 |
CPI plus 3% (%) | 8.4 | 13.5 | 7.0 | 5.5 | 6.4 |
ACWI (50% GBP) total return (%) | 20.0 | -12.9 | 18.4 | 20.1 | 17.1 |
Dividends paid in year (GBp) | 35.25 | 37.0 | 38.0 | 39.0 | 43.0 |
Net assets (GBP Mn) | — | — | 3,573 | 3,731 | 4,040 |
Key Financials and Margin Analysis (%)
| Metric | H1 2025 | FY2025 | H1 2026 | Sep 2026 |
|---|---|---|---|---|
NAV per share (GBp) | 2,680 | 2,921 | 3,159 | 3,209 |
Share price (GBp) | — | 2,270 | 2,290 | 2,540 |
Discount (%) | — | -22.3 | -27.5 | -20.8 |
Net assets (GBP Mn) | 3,750 | 4,040 | 4,289 | 4,000 |
Gearing (%) | — | 3.2 | 5.5 | 4.1 |
Income Statement and Per-Share Data
| Metric (GBP Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Investment income | 29.3 | 29.1 | — |
Total income incl. fair-value gains ("revenue" proxy) | 143.2 | 376.9 | — |
Operating expenses (total) | — | — | 41.0 |
Profit before tax | 66.1 | 305.0 | — |
Diluted EPS (GBp) | 43.8 | 210.2 | — |
Income Statement and Per-Share Data (Half-Yearly)
| Metric (GBP Mn unless stated) | H1 2025 | H1 2026 |
|---|---|---|
Investment income (revenue column) | 16.7 | 13.2 |
Other income | 0.2 | 0.2 |
Gains on fair-value investments (capital) | 128.1 | 346.8 |
Gains/(losses) on monetary items and borrowings | -3.2 | 3.4 |
Total income | 141.8 | 363.6 |
Operating expenses | -18.6 | -18.7 |
Profit before finance costs and tax | 123.2 | 344.9 |
Finance costs | -19.2 | -11.4 |
Profit before tax | 104.0 | 333.5 |
Taxation | 0.0 | 0.0 |
Profit for period | 104.0 | 333.5 |
Revenue EPS basic (GBp) | -1.9 | -3.2 |
Capital EPS basic (GBp) | 75.7 | 247.3 |
Total EPS basic (GBp) | 73.8 | 244.1 |
Total EPS diluted (GBp) | 73.5 | 243.1 |
Weighted basic shares (M) | 140.9 | 136.6 |
Balance Sheet
| Metric (GBP Mn) | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|
Investments held at fair value | 4,015.3 | 4,310.6 |
Investment property | 32.7 | 31.0 |
Property, plant and equipment | 22.3 | 25.4 |
Derivative assets (total) | 36.1 | 52.4 |
Other receivables | 61.2 | 103.7 |
Cash at bank | 220.6 | 226.8 |
Total assets | 4,388.2 | 4,749.9 |
Borrowings – current (RCFs) | 127.4 | 185.9 |
Borrowings – non-current (loan notes/term loan) | 174.8 | 175.0 |
Total borrowings | 302.2 | 360.9 |
Net debt (borrowings less cash) | 81.6 | 134.1 |
Derivative liabilities (total) | 2.4 | 69.3 |
Net current assets | 149.9 | 103.6 |
Net assets / total equity | 4,040.1 | 4,289.1 |
Goodwill and intangibles | 0 | 0 |
Group Structure
| Level | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|
Level 1 investments | 995.0 | 856.6 |
Level 2 investments | 961.8 | 1,514.2 |
Level 3 investments | 2,058.5 | 1,939.8 |
Level 3 incl. properties | 2,113.5 | 1,996.2 |
Cash Flow
| Metric (GBP Mn) | H1 2025 | H1 2026 |
|---|---|---|
Operating cash flow before interest | 95.3 | 59.9 |
Interest paid | -19.2 | -11.4 |
Net operating cash flow | 76.1 | 48.5 |
Capex (PP&E) | -0.1 | -0.1 |
"Free cash flow" (OCF less capex) | 76.0 | 48.4 |
Drawing of borrowings | 184.7 | 183.8 |
Repayment of borrowings | -149.3 | -128.0 |
Purchase of shares into treasury (buybacks) | -52.0 | -59.7 |
Purchase of shares by EBT | -6.9 | -2.7 |
Dividends paid | -30.4 | -30.7 |
Net change in cash | 22.1 | 11.1 |
Cash at period end | 221.2 | 226.8 |
Capital returns (GBP Mn)
| Capital returns (GBP Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 YTD Sep |
|---|---|---|---|---|---|
Share buybacks incl. tender | 11 | 163 | 80 | 89 | 373 |
Dividends paid (approx., GBP Mn) | — | — | — | — | 61 |
Margin Analysis (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|
NAV total return (ROE proxy, %) | 9.4 | 13.5 | 9.0 |
ROE (profit / average equity, %) | 8.4 | — | 8.0 |
ROA (profit / total assets, %) | — | — | 7.0 |
Gearing (AIC basis, %) | 8.9 | 3.2 | 5.5 |
Debt / equity (%) | — | 7.5 | 8.4 |
Net debt / net assets (%) | — | 2.0 | 3.1 |
Interest coverage (PBIT / finance costs, x) | — | — | 30.3 |
OCF ongoing charges (%) | 0.76 | 0.73 | — |
Geographic income (GBP Mn)
| Geographic income (GBP Mn) | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
United Kingdom | 541 | 918 | -529 | 142 | 375 |
Region Overview
| Region | % NAV |
|---|---|
North America | 54 |
Emerging Markets | 15 |
Global (gold, some absolute return/credit) | 10 |
Europe | 8 |
Japan | 7 |
United Kingdom | 4 |
Other | 2 |
Geographic Revenue
| Region | FY2024 | FY2025 |
|---|---|---|
US | 58 | 35 |
Europe | 8 | 24 |
Asia (ex-Japan) | 15 | 22 |
Japan | 17 | 17 |
Other | 2 | 2 |
Geographic Revenue (FY2024–Sep 2026)
| Currency | FY2024 | FY2025 | Sep 2026 |
|---|---|---|---|
Sterling | 57.9 | 68.4 | 56 |
US dollar | 25.7 | 17.0 | 34 |
Japanese yen | 4.3 | 3.5 | 4 |
Euro | 2.4 | 4.0 | 2 |
Chinese renminbi | — | — | 2 |
Other | 9.7 | 7.1 | 2 |
Total return (%) to 30 Sep 2026
| Total return (%) to 30 Sep 2026 | 1 Year | 2 Years | 3 Years | 5 Years | 10 Years |
|---|---|---|---|---|---|
Share price TR | 27.2 | 44.5 | 40.4 | 8.9 | 74.9 |
NAV per share TR | 14.2 | 26.3 | 39.5 | 26.4 | 124.7 |
ACWI (50% GBP) | 18.2 | 38.5 | 73.0 | 75.9 | 212.8 |
CPI plus 3% | 6.1 | 13.3 | 18.6 | 47.1 | 89.0 |
Price Data Details
| Price data | Value |
|---|---|
Close, 16 Oct 2026 | 2,505p (ADVFN) |
52-week range | 1,952p–2,645p (Yahoo) / 1,985p–2,645p (Google Finance) — vendor discrepancy noted |
Market capitalisation | ~£3.1bn |
Beta (5Y monthly, US OTC line) | 0.32 (Yahoo, RITPF — illiquid line; indicative only) |
Valuation Multiples
| Multiple | RIT | Comment |
|---|---|---|
Price / NAV (P/B) | 0.78x (2,505p / 3,209p) | Primary valuation metric; discount ~21.9% |
P/E | ~5x (Google Finance, trailing) | Not meaningful; earnings are mostly unrealised capital gains |
Dividend yield | 1.8% | 45p / ~2,505p |
Dividend per share (GBp)
| Dividend per share (GBp) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total dividend paid | 35.25 | 37.0 | 38.0 | 39.0 | 43.0 |
Capital Markets
| Item | Detail |
|---|---|
Authority | Up to 14.99% of issued share capital (renewed 30 April 2026 AGM) |
2026 YTD (Sept) | £373m incl. £300m tender (11.17m shares at £26.8515; cancelled) |
Since 2023 (to Jun 2026, regular buybacks) |
|
Treasury | 5,574,512 shares (4.29%) at 16 Oct 2026 |
Debt Facilities
| Facility | Lender | Terms | Status |
|---|---|---|---|
Senior loan notes (2015 programme) | Private placement | Fixed rate, original tenors 10–20 years; first series repaid H1 2025; remaining weighted average tenor 5.2 years (Jun 2026) | £125.8m fair value (Dec 2025) |
Term loan | BNP Paribas SA | Floating, three-year, drawn Sept 2024 (implies ~Sept 2027 maturity) | Drawn |
RCF | BNP Paribas SA | Floating; 3- or 6-month drawings | Revolving |
RCF | ICBC | Floating; additional £50m added post-June 2026 on same terms | Revolving |
RCF | SMBC Bank International | £100m, three-year (signed H1 2025) | Revolving |
Borrowings (GBP Mn) | Dec 2025 | Jun 2026 | — |
Short-term bank borrowings (RCFs, term loan) | 176.4 | 185.9 | — |
Senior loan notes / non-current | 125.8 | 175.0 | — |
Total drawn | 302.2 | 360.9 | — |
Committed undrawn | 155 | 100 | — |
Analyst Conclusions
Management guidance and messaging
No numerical guidance. Management's outlook (H1 2026, Sept 2026 factsheet) has four elements:
-
Caution on persistent inflation, tighter monetary conditions and elevated valuations.
-
Reservations about public semiconductor exuberance, with AI conviction expressed via privates.
-
Belief that non-US markets offer the most compelling opportunities "in recent memory".
-
The Board's commitment to continued buybacks and a dividend-policy review, with results in March 2027.
Consensus expectations
No sell-side consensus for NAV or earnings was identified. Investor expectations centre on discount trajectory, private-portfolio realisations and the 2027 dividend outcome.
Bull case
-
Private portfolio optionality: SpaceX is now liquid. Anthropic, Databricks, Cognition and Stripe are category leaders with recent up-rounds, and Cognition's September 2026 round was above carrying value. The two-year realisation record (70% above carrying value on directs) suggests NAV marks are conservative.
-
Discount compression mechanics: The tender plus continued buybacks shrank the discount from 27.5% (June) to 17.4% (July). A higher 2027 dividend and steady buybacks could anchor it nearer the high teens, adding ~5–8 points of TSR on top of NAV growth.
-
Diversified, lower-volatility compounding: Rising NAV (+19.7% over 12 months to June 2026) with Q1 2026 downside protection supports the "core diversifier" positioning for wealth managers, now with clearer cost disclosure under the CCI regime.
Bear case
-
Structural relative underperformance: NAV TR of 124.7% over ten years vs 212.8% for its own relative benchmark. The diversification premium has not compensated for lost equity upside, and investors may prefer cheaper passive or liquid alternatives.
-
Concentrated AI/private risk: ~36% of NAV is in privates heavily tilted to US tech/AI, valued with lags and Level 3 inputs. An AI repricing would hit the pillar that management relies on for differentiation.
-
Discount reversion and shrinkage: The post-tender discount already re-widened from 17.4% (July) to 20.8% (September). The tender shrank the trust by ~£300m, lifted gearing and consumed liquidity. Further tenders at a 15% discount may be needed, eroding scale.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing |
|---|---|
| Second 2026 interim dividend (22.5p) | 30 Oct 2026 |
| Monthly NAV and factsheets (discount trend; buyback pace) | Mid-month |
| Q3 private fund valuations feeding NAV (Cognition up-round impact) | Nov–Dec 2026 NAVs |
| SpaceX share price and any RIT disposal of SpaceX shares | Ongoing |
| FY2026 results, dividend-policy outcome, possible 2027 step-up | March 2027 |
| 2027 AGM (buyback authority, board composition) | April 2027 |
| Further capital-return actions (tender repeat, discount-control mechanism) | Unscheduled |
| Private realisations (IPO/M&A pipeline: Databricks, Stripe, Anthropic, Kraken) | Unscheduled |
| Sterling/US dollar, long-end yields, Middle East developments | Ongoing |
| Leadership stability at JRCM (CIO and CFO roles) | Ongoing |
Analyst verdict
RIT Capital Partners in late 2026 is a trust whose investment engine has demonstrably recovered while its equity story is still being rebuilt. Under Maggie Fanari, NAV per share has reached successive records (3,209p at 30 September 2026). Returns have been broad across all three pillars: 13.5% in 2025 and 10.7% year-to-date in 2026. The private book has proved its marks through realisations at meaningful premia, capped by SpaceX's IPO at four times invested capital. The portfolio is more concentrated, more global and more deliberately positioned around two coherent theses: multipolar fragmentation and AI application-layer value capture.
The investment case, however, is not primarily about NAV. It is about the 20%-plus discount, which has turned respectable NAV compounding into poor shareholder outcomes: a five-year share-price return of under 9% against 26% for NAV. The July 2026 tender was the Board's most decisive action in years. It was accretive and well received by long-term holders, with roughly 80% of shares not tendered. Yet the subsequent drift from a 17% back to a 21% discount shows that one-off liquidity does not by itself re-rate a trust whose relative performance against global equities remains weak and whose asset base is roughly 40% Level 3.
On balance, RIT offers asymmetric value for patient investors. At ~0.78x NAV, the market is attributing little or no value to an increasingly mature, realisable and arguably conservatively marked private portfolio. Meanwhile, buybacks, a likely dividend uplift in 2027 and continued realisations provide tangible support. The principal risks are an AI-valuation reset hitting the very holdings that underpin the differentiation thesis, and discount fatigue prompting further shrinkage. A sustainable re-rating likely requires two to three years of NAV returns closer to its global equity benchmark, coupled with a codified discount-management policy. Monitor the March 2027 results as the decisive checkpoint.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Board tenure | Committees / notes | Background |
|---|---|---|---|---|
Philippe Costeletos | Chairman (independent on appointment) | Joined Jul 2017; SID from Apr 2019; Chairman from 1 May 2025 | Chair of Nominations Committee from May 2025 | Founder, Stemar Capital Partners; former Chairman of International at Colony Capital; former Head of Europe at TPG; earlier Investcorp management committee, JP Morgan Capital, Morgan Stanley; Senior Advisor to Blackstone; BA Mathematics (Yale, magna cum laude), MBA (Columbia) |
Jutta af Rosenborg | Senior Independent Director | Joined May 2022; SID from May 2025 | Chair of Conflicts and Remuneration Committees | — |
Helena Coles | Independent NED | — | Member of Conflicts and Remuneration Committees | — |
Vikas Karlekar | Independent NED | Joined Aug 2022 | Member of Audit and Risk Committee | — |
Cecilia McAnulty | Independent NED | Joined Aug 2022 | — | SID of Northern 2 VCT; Audit Chair of Polar Capital Global Financials Trust; INED of Eurobank Cyprus |
André Perold | Independent NED | — | — | — |
Dame Hannah Rothschild DBE CBE | Non-independent NED (represents Rothschild family) | Joined Aug 2013 | Member of Nominations Committee | Daughter of Lord Jacob Rothschild; Chair of the Rothschild Foundation since 2024 |
Executive Leadership Team
| Name | Title | Tenure / notes | Prior roles / education |
|---|---|---|---|
Maggie Fanari | Chief Executive Officer, JRCM | CEO since March 2024 (announced Dec 2023/Jan 2024); RIT NED 2019–2024 | Senior Managing Director and global group head of high-conviction equities at Ontario Teachers' Pension Plan (joined 2006); British-Canadian; reported age 47 (Crain Currency, 2026) |
Cyril Martinez | Chief Strategy & Operating Officer | Listed on website (2025 photo) | — |
Andrew Jones | Chief Financial & Operating Officer (per Simply Wall St; may be outdated given Martinez's COO title) | — | — |
Nick (Nicholas) Khuu | Chief Investment Officer (succeeded Ron Tabbouche, late 2023) | — | Previously joint CIO |
Fahad Siddiqi | Head of Direct Equities | Website (2025) | — |
Garret Sheridan | Head of Investment Structuring | Website | — |
Holly Bradley | Director of Performance & Risk | Website | — |
Eleanor Wells | Senior Legal Counsel & Head of ESG | Website (2026) | — |
Katherine Parker | Head of Human Resources | Website | — |
Simon Amslinger | Investment Executive, Public Equities | Website | — |
Espen Ericsson | Investment Executive, Private Investments | Website (Dec 2025) | — |
Tom Hill | — | Listed by Simply Wall St | — |
Directors' Remuneration
| Item | Detail |
|---|---|
Remuneration structure | Annual Incentive Scheme (rewards investment outperformance and operational achievements) plus long-term incentive plan (share-based, for shareholder alignment); Board oversees Manager incentives with external advice (2025 AR) |
CEO total compensation (FY2025) | 78–81. Simply Wall St shows only a nominal figure (~£7.7k) reflecting her prior NED fee; this should not be read as CEO pay |
NED fees | Indicative figures from Simply Wall St (period unclear): Costeletos ~£80.5k; SID ~£66.6k; other NEDs ~£39k–£58k. |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Nov 2023 | CIO Ron Tabbouche resigns (advisory until year-end) | Relocation to Israel; Nick Khuu continues as CIO |
Mar 2024 | Francesco Goedhuis steps down as CEO, becomes senior adviser; Maggie Fanari appointed | Family illness; Goedhuis had been with RIT since 2010 |
26 Feb 2024 | Death of Lord Jacob Rothschild (Honorary President) | End of founder era |
1 May 2025 | Sir James Leigh-Pemberton retires as Chairman; Costeletos succeeds; af Rosenborg becomes SID | Planned succession |
2025–2026 | Website shows new hires: Head of Direct Equities (Fahad Siddiqi), Chief Strategy & Operating Officer (Cyril Martinez), Senior Legal Counsel & Head of ESG (Eleanor Wells) | Rebuild of the investment and operating team under Fanari |
Major Shareholders
| Holder | Stake | Shares | Source / date |
|---|---|---|---|
Rothschild family (aggregate) | ~22% | — | ritcap.com history page |
The Rothschild Foundation (endowment arm) | ~11.0–11.1% (pre-tender basis) | 15,390,848 | Simply Wall St (2025) |
Hargreaves Lansdown Asset Management | ~8.8–9.0% | ~12.2–12.6m | Simply Wall St (2025) |
Aberdeen Group | ~5.5–5.8% | ~7.6–8.2m | Simply Wall St (2025) |
Evelyn Partners (Professional Services Group and Investment Management LLP) | ~4.9% + ~4.8% | ~6.8m + ~6.7m | Simply Wall St (2025) |
Rathbones Investment Management | ~4.1% | — | Simply Wall St (2025) |
Charles Stanley & Co. | ~4.0% | — | Simply Wall St (2024–25) |
Competitive Landscape
Key Competitors
| Competitor | Ticker | Category | Relative positioning vs RIT |
|---|---|---|---|
Caledonia Investments | CLDN | Family-backed (Cayzer) self-managed multi-asset trust | Closest structural peer: family anchor, internal management, private-capital exposure, persistent discount |
Personal Assets Trust | PNL | Wealth preservation (Troy) | Lower-risk, liquid, discount-control mechanism; competes for "defensive core" money |
Capital Gearing Trust | CGT | Wealth preservation | Liquid, inflation-linked focus; strict discount control |
Ruffer Investment Company | RICA | Absolute return | Competes with RIT's "capital preservation" narrative |
Alliance Witan | ALW | Global multi-manager equity | Lower-cost, liquid global equity exposure |
Scottish Mortgage | SMT | Global growth incl. private companies | Competes for SpaceX/private-tech exposure; larger scale |
Pershing Square Holdings | PSH | Concentrated activist equity | Competes for "alternative" allocations; also trades at wide discount |
HarbourVest Global Private Equity | HVPE | Listed private equity fund-of-funds | Competes for private-markets exposure |
HgCapital Trust | HGT | Listed private equity (software) | Software-focused private exposure |
Monks Investment Trust | MNKS | Global growth | Global equity alternative |
BH Macro | BHMG | Macro hedge fund | Competes with RIT's Uncorrelated pillar |
Open-ended multi-asset/endowment-style funds | — | Various | Daily liquidity; no discount risk |
Peer Comparison FY2025
| Metric | RIT | Personal Assets |
|---|---|---|
Structure | Self-managed, family-anchored | Externally managed (Troy) |
Private asset exposure | ~36% NAV (Sept 2026) | Minimal |
Discount control | Buybacks + 2026 tender | Zero-discount policy historically |
Net assets / growth / margins / R&D | RIT ~£4.0bn net assets; NAV TR 13.5% FY2025 | — |



